Artificial Saliva Lozenges Pass the pH Test, Fail the Spit Test

The Oasis Health Journal · Submitted September 14, 2026 · 11:08 AM EDT

By Marlo Quist · Edited by Priya Raman, C.N.C.

Artificial saliva lozenges fix the number on the pH strip. They do not fix the part where your mouth feels like a sand trap.

Real saliva is thick. It coats. It sticks around.

Most dry mouth relief lozenges are phosphate buffer wearing a saliva costume.

Phosphate Buffer Lozenges Solve Half the Problem

A 2025 review in Pharmaceutics examined mucoadhesive drug delivery systems for the oral cavity. Mucoadhesion is the technical term for 'it sticks to your mouth lining instead of washing away in six seconds.'

The review noted that glycosaminoglycans and other naturally derived polysaccharides form hydrogels. These hydrogels have mucoadhesive properties. That means they hang around.

Real saliva hangs around because it contains mucin. Mucin is a glycoprotein. It is the reason spit has viscosity. It is the polymer net that holds water against tissue instead of letting it run down your throat.

A phosphate buffer system does chemistry. It brings your oral pH back to neutral. That is useful. Acidity damages enamel.

But pH is a number, not a texture.

Most artificial saliva lozenges restore the number. They do not restore the viscosity.

Saliva Substitute Products Often Skip the Mucin

A 2025 study in BMC Oral Health tested six commercially available saliva substitutes using a standardized Candida albicans biofilm assay. The trial adapted conditions to simulate the oral environment, including salivary pellicle formation.

Two specific oil-based substitutes, Aequasyal and Vea Oris, significantly enhanced fungal biofilm formation compared to phosphate buffered saline control.

The problem was not the pH. The problem was what the pH was riding around in.

Quartz crystal microbalance analysis showed that these oil-based formulas altered the structure of the salivary protein layer. The altered layer became a better surface for fungi.

The paper concluded that while oil-based saliva substitutes relieve xerostomia symptoms, they may promote Candida albicans biofilm formation in patients with a history of oral candidiasis. Clinicians were advised to favor water-based alternatives for high-risk individuals.

That is two jobs for saliva: lubricate the mouth, and do not invite fungus to the party.

Oil got one right.

How to Choose Artificial Saliva Products That Stick Around

A 2025 paper in Materials reviewed mucoadhesive antifungal systems for oral candidiasis. It noted that mucoadhesive formulations ensure prolonged retention and adequate drug concentrations at the site of treatment.

Mucoadhesion depends on the polymer. Common mucoadhesive agents include carbomers, cellulose derivatives, chitosan, and alginates. These form hydrogen bonds or electrostatic interactions with mucin.

Real saliva already has mucin. A substitute that mimics saliva needs something that behaves like mucin or bonds to what is left of it.

Most phosphate buffer oral lozenges are water, buffer salts, maybe some flavoring. They wet the mouth. They do not adhere to it.

If you are shopping for lozenges that help restore natural saliva feel, the ingredient list matters. Look for xanthan gum, carboxymethylcellulose, hyaluronic acid, or another named thickener.

If the ingredient list is monosodium phosphate and flavor, you are buying wet pH paper.

That is not criticism. That is labeling.

Oral Lozenges for Comfort and pH Are Not the Same Product

A 2025 study in International Journal of Oral Science grew human salivary gland cell spheroids in three types of reversible hydrogels: alginate-gelatin, collagen-containing alginate-gelatin, and hyaluronic acid-containing alginate-gelatin. The gels were tuned to match the mechanical properties of human salivary tissue, around 11 kilopascals.

Spheroids cultured in the hyaluronic acid gels maintained high expression of aquaporin-5, the water channel protein, and responded to stimulation by increasing secretory granules.

The study was not about lozenges. It was about tissue engineering. But it showed that the physical environment matters.

Viscosity is not decoration.

A separate 2025 paper in Inflammation tested aspirin-triggered resolvin D1 in mice engineered to express the human formyl peptide receptor 2. Mice were first treated with lipopolysaccharide to induce acute sialadenitis: inflamed salivary glands, reduced saliva secretion. When these mice were then given AT-RvD1, they showed reduced inflammation and restored saliva flow comparable to healthy controls.

That work was in mice. It measured actual saliva volume, not surrogate markers.

Most saliva substitute research measures pH, subjective comfort, and maybe mucosal moisture. Nobody is measuring whether the substitute actually mimics the mechanical job saliva does.

The Pharmaceutics review noted the gap plainly: standardized mucoadhesion and permeation assays are still lacking. In vitro results do not reliably predict in vivo performance.

We have lozenges that pass a pH test. We do not have a standardized spit test.

A pH balanced mouth lozenge is one thing. A lozenge that coats like spit is another. If the label does not say mucoadhesive, mucomimetic, or name a thickening polymer, it probably does not coat.

You can call it a saliva substitute if it gets your mouth wet. The mouth does not care what you call it.

This article is education and reporting on published research. It is not medical advice, and nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to your own clinician about your own situation.

Sources

1. Why Does Mucoadhesion Matter? Mucoadhesive Drug Delivery Systems with Antifungal Activity in the Local Treatment of Oral Cavity Candidiasis, Materials (Basel, Switzerland) (2025).
2. Oil-based saliva substitutes promote Candida albicans biofilm formation in vitro, BMC oral health (2025).
3. Nitrate maintains mitochondrial membrane integrity by increasing Sialin-FKBP8 granules via liquid-liquid-phase separation, Redox biology (2025).
4. Activation of Human FPR2 with AT-RvD1 Resolves Acute Sialadenitis in Vivo, Inflammation (2025).
5. Targeting the Oral Mucosa: Emerging Drug Delivery Platforms and the Therapeutic Potential of Glycosaminoglycans, Pharmaceutics (2025).
6. Cytotoxicity and Endocrine Disruption in Materials Used for Removable Orthodontic Retainers: A Comprehensive Review, Dentistry journal (2025).
7. Expansion of functional human salivary acinar cell spheroids with reversible thermo-ionically crosslinked 3D hydrogels, International journal of oral science (2025).